Daily Archives: January 31, 2021

COVID Multivalent vaccines for multivariant viruses

By on .

Preventing re-infections, more variants, and a prolonged pandemic By Daniel R. Lucey MD, MPH, FIDSA Emerging data since mid-January from South Africa and northern Brazil signal it is imperative to develop multivalent COVID vaccines (bivalent, trivalent, quadrivalent) for international use. An alternative strategy that is unlikely to succeed internationally is monovalent “booster” vaccines containing either […]